US5718355A
(en)
*
|
1989-02-03 |
1998-02-17 |
Senetics, Inc. |
Indicator device responsive to axial force for use with inhaler
|
US5020527A
(en)
*
|
1990-02-20 |
1991-06-04 |
Texax-Glynn Corporation |
Inhaler device with counter/timer means
|
SK280967B6
(sk)
*
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Inhalačný prístroj
|
YU48707B
(sh)
*
|
1990-03-02 |
1999-07-28 |
Glaxo Group Limited |
Aparat za inhaliranje - inhalator
|
US6536427B2
(en)
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
GB9015522D0
(en)
*
|
1990-07-13 |
1990-08-29 |
Braithwaite Philip W |
Inhaler
|
GB9026025D0
(en)
*
|
1990-11-29 |
1991-01-16 |
Boehringer Ingelheim Kg |
Inhalation device
|
US5243970A
(en)
*
|
1991-04-15 |
1993-09-14 |
Schering Corporation |
Dosing device for administering metered amounts of powdered medicaments to patients
|
US5327883A
(en)
*
|
1991-05-20 |
1994-07-12 |
Dura Pharmaceuticals, Inc. |
Apparatus for aerosolizing powdered medicine and process and using
|
ES2141108T3
(es)
*
|
1991-07-02 |
2000-03-16 |
Inhale Inc |
Metodo y dispositivo para proporcionar medicamentos en aerosol.
|
US6681767B1
(en)
|
1991-07-02 |
2004-01-27 |
Nektar Therapeutics |
Method and device for delivering aerosolized medicaments
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
SE9201411D0
(sv)
*
|
1992-05-05 |
1992-05-05 |
Astra Ab |
Dosage inhalator with indicating/interupting means
|
GB9211436D0
(en)
*
|
1992-05-29 |
1992-07-15 |
Norton Healthcare Ltd |
Dose indicating device
|
US5394868A
(en)
*
|
1992-06-25 |
1995-03-07 |
Schering Corporation |
Inhalation device for powdered medicaments
|
US5284133A
(en)
*
|
1992-07-23 |
1994-02-08 |
Armstrong Pharmaceuticals, Inc. |
Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means
|
BR9307270A
(pt)
*
|
1992-10-19 |
1999-06-01 |
Dura Pharma Inc |
Inalador de pó seco
|
DE4239402A1
(de)
*
|
1992-11-24 |
1994-05-26 |
Bayer Ag |
Pulverinhalator
|
US5383373A
(en)
*
|
1992-12-08 |
1995-01-24 |
Littlepoint Corporation |
Method for measuring topical dosage dispensed
|
US7849393B1
(en)
|
1992-12-09 |
2010-12-07 |
Discovery Communications, Inc. |
Electronic book connection to world watch live
|
US8073695B1
(en)
|
1992-12-09 |
2011-12-06 |
Adrea, LLC |
Electronic book with voice emulation features
|
US7509270B1
(en)
|
1992-12-09 |
2009-03-24 |
Discovery Communications, Inc. |
Electronic Book having electronic commerce features
|
US7336788B1
(en)
*
|
1992-12-09 |
2008-02-26 |
Discovery Communicatoins Inc. |
Electronic book secure communication with home subsystem
|
US7401286B1
(en)
|
1993-12-02 |
2008-07-15 |
Discovery Communications, Inc. |
Electronic book electronic links
|
EP0856993B1
(en)
|
1992-12-09 |
2002-07-31 |
Discovery Communications, Inc. |
Set top terminal for cable television delivery systems
|
US7835989B1
(en)
|
1992-12-09 |
2010-11-16 |
Discovery Communications, Inc. |
Electronic book alternative delivery systems
|
SE9203743D0
(sv)
*
|
1992-12-11 |
1992-12-11 |
Astra Ab |
Efficient use
|
US6250300B1
(en)
|
1992-12-11 |
2001-06-26 |
Ab Astra |
System for dispensing pharmaceutically active compounds
|
MY115140A
(en)
*
|
1992-12-18 |
2003-04-30 |
Schering Corp |
Inhaler for powdered medications
|
KR960701672A
(ko)
*
|
1993-03-03 |
1996-03-28 |
윌리엄 피. 알트만 |
건조 분말 흡입기의 약제 캐리어(dry powder inhalator medicament carrier)
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US5506203C1
(en)
*
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US5830853A
(en)
*
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
CN1045759C
(zh)
*
|
1993-09-22 |
1999-10-20 |
塞尼提克斯公司 |
轴向力作用的显示装置
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
US7865567B1
(en)
|
1993-12-02 |
2011-01-04 |
Discovery Patent Holdings, Llc |
Virtual on-demand electronic book
|
US8095949B1
(en)
|
1993-12-02 |
2012-01-10 |
Adrea, LLC |
Electronic book with restricted access features
|
US7861166B1
(en)
|
1993-12-02 |
2010-12-28 |
Discovery Patent Holding, Llc |
Resizing document pages to fit available hardware screens
|
US9053640B1
(en)
|
1993-12-02 |
2015-06-09 |
Adrea, LLC |
Interactive electronic book
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
AU124387S
(en)
*
|
1994-03-25 |
1995-08-11 |
Astra Ab |
Training device for an inhaler
|
US5482030A
(en)
*
|
1994-06-13 |
1996-01-09 |
Klein; David |
Aerosol and non-aerosol spray counter
|
US6165976A
(en)
*
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
AU697676B2
(en)
*
|
1994-09-21 |
1998-10-15 |
Nektar Therapeutics |
Apparatus and methods for dispersing dry powder medicaments
|
TW250616B
(en)
|
1994-11-07 |
1995-07-01 |
Discovery Communicat Inc |
Electronic book selection and delivery system
|
SE9404140D0
(sv)
*
|
1994-11-29 |
1994-11-29 |
Astra Ab |
Dose indicating device
|
DK0806945T3
(da)
*
|
1994-12-22 |
2003-08-04 |
Astrazeneca Ab |
Terapeutisk præparat til inhalering, indeholdende parathyroideahormon, PTH
|
US6524557B1
(en)
*
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
NZ298169A
(en)
|
1994-12-22 |
1999-09-29 |
Astra Ab |
Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
|
US20040237961A1
(en)
*
|
1995-06-08 |
2004-12-02 |
Snow John Medlin |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
US6672304B1
(en)
|
1995-06-08 |
2004-01-06 |
Innovative Devices, Llc |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
HU220227B
(hu)
*
|
1995-06-21 |
2001-11-28 |
Asta Medica A.G. |
Gyógyszerporos patron integrált adagolószerkezettel és inhalálókészülék poralakú gyógyszerekhez
|
US5988163A
(en)
*
|
1995-08-02 |
1999-11-23 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
|
US6209538B1
(en)
|
1995-08-02 |
2001-04-03 |
Robert A. Casper |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5692496A
(en)
*
|
1995-08-02 |
1997-12-02 |
Innovative Devices, Llc |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5823183A
(en)
*
|
1995-08-02 |
1998-10-20 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
FI102875B
(fi)
*
|
1995-11-10 |
1999-03-15 |
Orion Yhtymae Oy |
Jauheinhalaattori
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
DE19549033C1
(de)
*
|
1995-12-28 |
1997-05-28 |
Boehringer Ingelheim Int |
Mechanisches Zählwerk für ein Dosiergerät
|
RU2195965C2
(ru)
|
1996-02-21 |
2003-01-10 |
Шеринг Корпорейшн |
Устройство для ингаляции порошка
|
GB9610821D0
(en)
*
|
1996-05-23 |
1996-07-31 |
Glaxo Wellcome Inc |
Metering apparatus
|
GB9616047D0
(en)
|
1996-07-31 |
1996-09-11 |
Glaxo Group Ltd |
Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
|
GB2320489A
(en)
|
1996-12-20 |
1998-06-24 |
Norton Healthcare Ltd |
Inhaler dose counter
|
SE9700940D0
(sv)
*
|
1997-03-14 |
1997-03-14 |
Astra Ab |
Powder inhaler IV
|
SE9700944D0
(sv)
*
|
1997-03-14 |
1997-03-14 |
Astra Ab |
Powder inhaler VI
|
SE9700939D0
(sv)
*
|
1997-03-14 |
1997-03-14 |
Astra Ab |
Powder inhaler III
|
SE9700938D0
(sv)
*
|
1997-03-14 |
1997-03-14 |
Astra Ab |
Powder inhaler II and a method of construction thereof
|
DE69918267T2
(de)
|
1998-01-16 |
2005-07-28 |
1263152 Ontario Inc., London |
Anzeigevorrichtung zur verwendung mit einer abgabevorrichtung
|
US6142339A
(en)
*
|
1998-01-16 |
2000-11-07 |
1263152 Ontario Inc. |
Aerosol dispensing device
|
US7143764B1
(en)
|
1998-03-13 |
2006-12-05 |
Astrazeneca Ab |
Inhalation device
|
US6336453B1
(en)
|
1999-04-30 |
2002-01-08 |
Trudell Medical International |
Indicating device for aerosol container
|
US6082358A
(en)
*
|
1998-05-05 |
2000-07-04 |
1263152 Ontario Inc. |
Indicating device for aerosol container
|
US6729330B2
(en)
|
1998-05-05 |
2004-05-04 |
Trudell Medical International |
Indicating device for aerosol container
|
US6257233B1
(en)
|
1998-06-04 |
2001-07-10 |
Inhale Therapeutic Systems |
Dry powder dispersing apparatus and methods for their use
|
JP2000217917A
(ja)
*
|
1999-01-27 |
2000-08-08 |
Unisia Jecs Corp |
吸入式投薬器
|
EP1169053A1
(en)
|
1999-04-13 |
2002-01-09 |
Inhale Therapeutic Systems, Inc. |
Pulmonary administration of dry powder formulations for treating infertility
|
ATE294608T1
(de)
|
1999-06-05 |
2005-05-15 |
Innovata Biomed Ltd |
Verabreichungsystem für medikamente
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
GB9920839D0
(en)
|
1999-09-04 |
1999-11-10 |
Innovata Biomed Ltd |
Inhaler
|
AU775565B2
(en)
*
|
1999-10-29 |
2004-08-05 |
Novartis Ag |
Dry powder compositions having improved dispersivity
|
JP2003516200A
(ja)
*
|
1999-12-07 |
2003-05-13 |
オリオン コーポレーション |
多数回投与パウダー吸入器
|
US6679256B2
(en)
|
1999-12-17 |
2004-01-20 |
Nektar Therapeutics |
Systems and methods for extracting powders from receptacles
|
US6948494B1
(en)
*
|
2000-05-10 |
2005-09-27 |
Innovative Devices, Llc. |
Medicament container with same side airflow inlet and outlet and method of use
|
GB2364649A
(en)
*
|
2000-05-17 |
2002-02-06 |
Orion Corp |
Inhaler with Dose Counter
|
AR028746A1
(es)
*
|
2000-06-23 |
2003-05-21 |
Norton Health Care Ltd |
Cartucho de dosis previamente medidas para inhalador de polvo seco accionado por la respiracion, el inhalador y un metodo de provision de dosis previamente medidas de polvo seco
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
ES2291452T3
(es)
*
|
2001-02-06 |
2008-03-01 |
Innovata Biomed Limited |
Formulacion bimodal de polvo seco para inhalacion.
|
US6745760B2
(en)
|
2001-05-15 |
2004-06-08 |
Trudell Medical International |
Medicament applicator
|
JP2007528691A
(ja)
|
2001-11-14 |
2007-10-18 |
セントカー・インコーポレーテツド |
抗il−6抗体、組成物、方法および使用
|
GB0128148D0
(en)
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
ATE508735T1
(de)
|
2001-12-19 |
2011-05-15 |
Novartis Ag |
Pulmonale verabreichung von aminoglykosiden
|
US6929798B2
(en)
*
|
2002-02-13 |
2005-08-16 |
Immunology Laboratories, Inc. |
Compositions and methods for treatment of microbial infections
|
ES2425392T3
(es)
|
2002-03-20 |
2013-10-15 |
Mannkind Corporation |
Cartucho para un aparato de inhalación
|
US7004164B2
(en)
*
|
2002-03-21 |
2006-02-28 |
Trudell Medical International |
Indicating device for aerosol container
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
GB0208609D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Compositions
|
AU2003280130B2
(en)
|
2002-06-28 |
2009-06-11 |
Centocor, Inc. |
Mammalian CH1 deleted mimetibodies, compositions, methods and uses
|
GB0316335D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
UA89481C2
(uk)
|
2003-09-30 |
2010-02-10 |
Центокор, Инк. |
Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
|
GB0324897D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
US7621273B2
(en)
|
2003-10-28 |
2009-11-24 |
Trudell Medical International |
Indicating device with warning dosage indicator
|
WO2005040163A1
(en)
*
|
2003-10-28 |
2005-05-06 |
Dr. Reddy's Laboratories Ltd |
Heterocyclic compounds that block the effects of advanced glycation end products (age)
|
KR100568374B1
(ko)
|
2003-11-11 |
2006-04-05 |
주식회사 히타치엘지 데이터 스토리지 코리아 |
광디스크 장치에서의 디스크 유형 판별방법
|
US7100530B2
(en)
|
2003-12-15 |
2006-09-05 |
Trudell Medical International, Inc. |
Dose indicating device
|
EP1701714A2
(en)
*
|
2004-01-07 |
2006-09-20 |
Nektar Therapeutics |
Improved sustained release compositions for pulmonary administration of insulin
|
US20050186146A1
(en)
*
|
2004-02-12 |
2005-08-25 |
Nektar Therapeutics |
Interleukin-13 antagonist powders, spray-dried particles, and methods
|
ES2435397T3
(es)
*
|
2004-02-16 |
2013-12-19 |
Glaxo Group Limited |
Contador para utilizar con un dispensador de medicamentos
|
CA2563379A1
(en)
*
|
2004-03-31 |
2005-10-20 |
Centocor, Inc. |
Human glp-1 mimetibodies, compositions, methods and uses
|
EP1744800B1
(en)
*
|
2004-04-21 |
2016-06-22 |
Innovata Biomed Limited |
Inhaler
|
GB0409197D0
(en)
|
2004-04-24 |
2004-05-26 |
Innovata Biomed Ltd |
Device
|
EP1765288B1
(en)
|
2004-06-18 |
2012-11-07 |
Novartis AG |
Tobramycin formualtions for treatment of endobronchial infections
|
SI1616592T1
(sl)
*
|
2004-07-16 |
2011-03-31 |
Almirall Sa |
Inhalator za uporabo farmacevtskih snovi v prahu in vloĹľek za prah za uporabo s tem inhalatorjem
|
ATE486064T1
(de)
|
2004-08-20 |
2010-11-15 |
Mannkind Corp |
Katalyse der diketopiperazinsynthese
|
PL1791542T3
(pl)
|
2004-08-23 |
2015-11-30 |
Mannkind Corp |
Sole diketopiperazyny do dostarczania leków
|
US7393662B2
(en)
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
US7543582B2
(en)
|
2004-09-20 |
2009-06-09 |
Trudell Medical International |
Dose indicating device with display elements attached to container
|
CN101810901B
(zh)
|
2005-01-20 |
2013-07-24 |
特鲁德尔医学国际公司 |
分配装置
|
PE20061324A1
(es)
|
2005-04-29 |
2007-01-15 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, metodos y usos
|
TR201902033T4
(tr)
|
2005-06-30 |
2019-03-21 |
Janssen Biotech Inc |
Anti-IL-23 antikorları, bileşimleri, yöntemleri ve kullanımları.
|
AU2006290870B2
(en)
|
2005-09-14 |
2013-02-28 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
|
JP5096363B2
(ja)
*
|
2005-12-16 |
2012-12-12 |
ネクター セラピューティックス |
Glp−1のポリマ複合体
|
MX2008008621A
(es)
|
2005-12-29 |
2008-11-27 |
Centocor Inc |
Anticuerpos anti-il-23 humanos, composiciones, metodos y usos.
|
EP2497484A3
(en)
|
2006-02-22 |
2012-11-07 |
MannKind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
GB0605150D0
(en)
*
|
2006-03-14 |
2006-04-26 |
Glaxo Group Ltd |
Counter For Use With A Medicament Dispenser
|
US20100034819A1
(en)
*
|
2006-03-31 |
2010-02-11 |
Centocor Inc. |
Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions on renal disease associated anemia
|
US8141550B2
(en)
|
2006-08-01 |
2012-03-27 |
Trudell Medical International |
Dispensing device
|
DK2068889T3
(da)
|
2006-08-10 |
2020-02-03 |
Roy C Levitt |
Anakinra til anvendelse i behandling af bronchiolitis obliterans syndrom
|
UY30820A1
(es)
*
|
2006-12-21 |
2008-07-03 |
Centocor Inc |
Uso de agonistas del receptor de glp-1 de accion prolongada para mejorar la sensibilidad a la insulina y los perfiles lipidicos
|
GB0706405D0
(en)
*
|
2007-04-02 |
2007-05-09 |
3M Innovative Properties Co |
Dose counter
|
ES2394589T3
(es)
|
2007-12-14 |
2013-02-04 |
Aerodesigns, Inc |
Suministro de productos alimenticios transformables en aerosol
|
US8082873B2
(en)
|
2008-05-05 |
2011-12-27 |
Trudell Medical International |
Drive mechanism for an indicating device
|
US8181591B1
(en)
|
2008-05-23 |
2012-05-22 |
Trudell Medical International |
Domed actuator for indicating device
|
DK2570147T3
(da)
|
2008-06-13 |
2018-01-29 |
Mannkind Corp |
Tørpulverinhalator og system til lægemiddelindgivelse
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
KR101628410B1
(ko)
|
2008-06-20 |
2016-06-08 |
맨카인드 코포레이션 |
흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
NZ590816A
(en)
|
2008-08-14 |
2013-02-22 |
Cephalon Australia Pty Ltd |
Anti-il-12/il-23 antibodies
|
US20110105383A1
(en)
*
|
2008-09-10 |
2011-05-05 |
Magnus Hook |
Methods and compositions for stimulation of mammalian innate immune resistance to pathogens
|
CA2905402C
(en)
|
2008-10-22 |
2017-02-28 |
Trudell Medical International |
Modular aerosol delivery system
|
PL2356269T3
(pl)
|
2008-10-31 |
2016-12-30 |
|
Kompozycje białek rusztowania oparte na domenie fibronektyny typu III, sposoby i zastosowania
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
CN102596992B
(zh)
|
2009-02-12 |
2015-09-09 |
詹森生物科技公司 |
基于ⅲ型纤连蛋白结构域的支架组合物、方法及用途
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
PT2411521E
(pt)
|
2009-03-25 |
2015-04-21 |
Univ Texas |
Composições para estimulação de resistência imunitária inata de mamíferos contra patogénicos
|
US8734845B2
(en)
|
2009-06-12 |
2014-05-27 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
AU2011215900A1
(en)
|
2010-02-10 |
2012-07-26 |
Immunogen, Inc. |
CD20 antibodies and uses thereof
|
US9022988B1
(en)
|
2010-05-07 |
2015-05-05 |
Kavan J. Shaban |
System and method for controlling a self-injector device
|
KR101834026B1
(ko)
|
2010-06-19 |
2018-03-02 |
메모리얼 슬로안-케터링 캔서 센터 |
항-gd2 항체
|
RU2531455C2
(ru)
|
2010-06-21 |
2014-10-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
EA201591390A1
(ru)
|
2010-06-24 |
2016-06-30 |
Джилид Сайэнс, Инк. |
Пиразол[1,5-a]пиримидины для противовирусного лечения
|
CR20170278A
(es)
|
2010-07-22 |
2017-09-29 |
Gilead Sciences Inc |
Métodos y compuestos para tratar infecciones virales por paramyxoviridae
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之2’-氟取代之碳-核苷類似物
|
MY180552A
(en)
|
2011-04-01 |
2020-12-02 |
Mannkind Corp |
Blister package for pharmaceutical cartridges
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
WO2012175735A1
(en)
|
2011-06-23 |
2012-12-27 |
Vib Vzw |
A20 inhibitors for the treatment of respiratory viral infections
|
WO2013063160A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
EP3351552B1
(en)
|
2012-03-13 |
2021-05-19 |
Gilead Sciences, Inc. |
2'-substituted carba-nucleoside analogs for antiviral treatment
|
CN106986869A
(zh)
|
2012-04-17 |
2017-07-28 |
吉利德科学公司 |
用于抗病毒治疗的化合物和方法
|
CA2878457C
(en)
|
2012-07-12 |
2021-01-19 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
TW201427681A
(zh)
|
2013-01-07 |
2014-07-16 |
Superlab Far East Ltd |
用空間構象改變的重組干擾素治療腫瘤的方法
|
WO2014116122A1
(en)
|
2013-01-22 |
2014-07-31 |
Fisher & Paykel Healthcare Limited |
Dual-connector wye piece
|
US9452139B2
(en)
|
2013-03-14 |
2016-09-27 |
Novartis Ag |
Respirable agglomerates of porous carrier particles and micronized drug
|
EP2968545B1
(en)
|
2013-03-15 |
2019-03-06 |
Memorial Sloan Kettering Cancer Center |
High affinity anti-gd2 antibodies
|
BR112015023168B1
(pt)
|
2013-03-15 |
2021-08-10 |
Mannkind Corporation |
Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
|
CN114848614A
(zh)
|
2013-07-18 |
2022-08-05 |
曼金德公司 |
热稳定性干粉药物组合物和方法
|
CA2920488C
(en)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Insufflation apparatus and methods
|
UA119050C2
(uk)
|
2013-11-11 |
2019-04-25 |
Ґілеад Саєнсиз, Інк. |
ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
TWI678369B
(zh)
|
2014-07-28 |
2019-12-01 |
美商基利科學股份有限公司 |
用於治療呼吸道合胞病毒感染之噻吩並[3,2-d]嘧啶、呋喃並[3,2-d]嘧啶及吡咯並[3,2-d]嘧啶化合物類
|
TWI673283B
(zh)
|
2014-08-21 |
2019-10-01 |
美商基利科學股份有限公司 |
2’-氯胺基嘧啶酮及嘧啶二酮核苷類
|
WO2016044839A2
(en)
|
2014-09-19 |
2016-03-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
CN104443829A
(zh)
*
|
2014-10-31 |
2015-03-25 |
徐根彪 |
内置式粉状食品定量供给装置
|
AU2016233309B2
(en)
|
2015-03-17 |
2021-11-18 |
Memorial Sloan Kettering Cancer Center |
Anti-MUC16 antibodies and uses thereof
|
MX2019000641A
(es)
|
2016-07-15 |
2019-06-10 |
Poseida Therapeutics Inc |
Composiciones de mucina1-receptor de antigeno quimerico y metodos para su uso.
|
JP2019524721A
(ja)
|
2016-07-15 |
2019-09-05 |
ポセイダ セラピューティクス, インコーポレイテッド |
キメラ抗原受容体および使用方法
|
BR112019009469A2
(pt)
|
2016-11-09 |
2019-07-30 |
Pulmotect Inc |
métodos e composições para a modulação imunológica adaptativa
|
WO2018112037A1
(en)
|
2016-12-16 |
2018-06-21 |
Jia Zhou |
Inhibitors of bromodomain-containing protein 4 (brd4)
|
DE102016015551A1
(de)
|
2016-12-22 |
2018-06-28 |
Olaf Minet |
Vorrichtung und Verfahren zur effektiven Inhalation von flüssigen oder pulverförmigen Wirkstoffen
|
EP3574012A1
(en)
|
2017-01-27 |
2019-12-04 |
Memorial Sloan Kettering Cancer Center |
Bispecific her2 and cd3 binding molecules
|
CN110234351A
(zh)
|
2017-01-30 |
2019-09-13 |
詹森生物科技公司 |
用于治疗活动性银屑病关节炎的抗tnf抗体、组合物和方法
|
CN110418652A
(zh)
|
2017-02-07 |
2019-11-05 |
詹森生物科技公司 |
用于治疗活动性强直性脊柱炎的抗tnf抗体、组合物和方法
|
KR20200116917A
(ko)
|
2017-12-20 |
2020-10-13 |
포세이다 테라퓨틱스, 인크. |
Vcar 조성물 및 사용 방법
|
MA52590A
(fr)
|
2018-05-11 |
2021-03-17 |
Janssen Biotech Inc |
Méthodes de traitement de la dépression à l'aide d'anticorps il-23
|
US11389433B2
(en)
|
2018-06-18 |
2022-07-19 |
Board Of Regents, The University Of Texas System |
BRD4 inhibitor treatment of IgE-mediated diseases
|
JP2022518208A
(ja)
|
2019-01-15 |
2022-03-14 |
ヤンセン バイオテツク,インコーポレーテツド |
若年性特発性関節炎の治療のための抗tnf抗体、組成物、及び方法
|
WO2020152544A1
(en)
|
2019-01-23 |
2020-07-30 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis
|
KR20210142002A
(ko)
|
2019-03-14 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-tnf 항체 조성물을 생성하기 위한 제조 방법
|
CA3133388A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Methods for producing anti-tnf antibody compositions
|
MA55283A
(fr)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech Inc |
Procédés de production de compositions d'anticorps anti-tnf
|
US11780911B2
(en)
|
2019-05-23 |
2023-10-10 |
Janssen Biotech, Inc. |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
|
CN113939531A
(zh)
|
2019-06-03 |
2022-01-14 |
詹森生物科技公司 |
用于治疗银屑病关节炎的抗tnf抗体组合物和方法
|
MX2021014882A
(es)
|
2019-06-03 |
2022-03-25 |
Janssen Biotech Inc |
Anticuerpos anti-tnf, composiciones y métodos para el tratamiento de la espondilitis anquilosante activa.
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
CA3165735A1
(en)
|
2019-12-24 |
2021-07-01 |
Carna Biosciences, Inc. |
Diacylglycerol kinase modulating compounds
|
TWI794742B
(zh)
|
2020-02-18 |
2023-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
US20210292348A1
(en)
|
2020-02-18 |
2021-09-23 |
Gilead Sciences, Inc. |
Antiviral compounds
|
TWI775313B
(zh)
|
2020-02-18 |
2022-08-21 |
美商基利科學股份有限公司 |
抗病毒化合物
|
TWI791193B
(zh)
|
2020-02-18 |
2023-02-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
US20230190811A1
(en)
|
2020-04-14 |
2023-06-22 |
Poseida Therapeutics, Inc. |
Compositions and methods for use in the treatment of cancer
|
WO2021214587A1
(en)
|
2020-04-21 |
2021-10-28 |
Janssen Biotech, Inc. |
Anti-tnf alpha agent for treating viral infections
|
WO2021214588A1
(en)
|
2020-04-21 |
2021-10-28 |
Janssen Biotech, Inc. |
Anti-tnf alpha agent for treating coronavirus infections
|
US20230039553A1
(en)
|
2020-05-01 |
2023-02-09 |
Gilead Sciences, Inc. |
Cd73 compounds
|
CN116782920A
(zh)
|
2020-07-31 |
2023-09-19 |
常青树治疗公司 |
用于治疗病毒感染的神经毡蛋白和血管紧张素转化酶2融合肽
|
AU2022298639A1
(en)
|
2021-06-23 |
2023-12-07 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
CA3220923A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
US11976072B2
(en)
|
2021-06-23 |
2024-05-07 |
Gilead Sciences, Inc. |
Diacylglycerol kinase modulating compounds
|
US11926628B2
(en)
|
2021-06-23 |
2024-03-12 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
WO2023279115A1
(en)
|
2021-07-02 |
2023-01-05 |
Henry Ford Health System |
Compositions comprising endosidin 2 for reducing sars-cov-2 infection
|
WO2023281462A1
(en)
|
2021-07-09 |
2023-01-12 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
CN117957251A
(zh)
|
2021-07-09 |
2024-04-30 |
詹森生物科技公司 |
用于制备抗tnf抗体组合物的制造方法
|
AU2022376954A1
(en)
|
2021-10-29 |
2024-05-02 |
Gilead Sciences, Inc. |
Cd73 compounds
|